Veradigm | MDRX - Ebitda

Aktienkurs
4.55
Täglich Wechseln
-0.03 -0.66%
Monatlich
1.11%
Jährlich
4.36%
Q1 Prognose
4.44




Ebitda Veränderung Datum
Alcidion AUD 4.19M 365K 2025-12
Ambu A/S DKK 261M 17M 2025-12
Amplifon EUR 107.33M 38.85M 2025-09
Cardinal Health USD 981M 5M 2025-12
Centene USD -903M 1.02B 2025-12
Charles River Laboratories USD 258.06M 24.83M 2025-12
Cigna USD 2.86B 56M 2025-03
Coloplast 2.39B 132M 2025-09
Convatec Group USD 286.8M 27.5M 2024-12
CVS Health USD 3.74B 349M 2025-12
Diasorin EUR 92M 5M 2025-12
Elevance Health USD 2.19B 1.01B 2025-09
General Electric Aerospace USD 3.04B 185M 2025-09
Gulf Medical Proj AED 35.5M 2.9M 2025-03
Humana USD -290M 1.11B 2025-12
IQVIA Holdings USD 1.05B 97M 2025-12
Laboratory Of America USD 588.1M 24.1M 2025-12
Maximus USD 170.41M 10.34M 2025-12
McKesson USD 1.68B 418M 2025-09
Med Life RON 108.31M 30.25M 2025-09
Molina Healthcare USD 185M 265M 2025-09
Omnicell USD 41.13M 2.76M 2025-09
Oriola-kd EUR 9.9M 300K 2025-12
Owens Minor USD 90.02M 2.15M 2025-12
Quest Diagnostics USD 537M 24M 2025-12
Rede D'or Sao Luiz BRL 3.09B 186.94M 2025-12
Siemens Healthineers EUR 1.11B 83M 2025-12
Supermax Corporation Bhd MYR -141.38M 42.01M 2025-09
UnitedHealth USD 1.5B 3.92B 2025-12
Veeva Systems USD 374.79M 3.96M 2025-12
Veradigm USD 38.81M 29.61M 2022-09
Xerox USD 110M 54M 2025-06